Exandal Corp.:企業の戦略・SWOT・財務情報

◆英語タイトル:Exandal Corp. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6295
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Exandal Corp. – Strategy, SWOT and Corporate Finance Report
Summary

Exandal Corp. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Exandal Corp. (Exandal) is a manufacturer and distributor of food ingredients. The company’s product portfolio includes carrageenan, xanthan gum, tara gum, tara powder and tara germ. Exandal markets its products under the brands of Tara Gum and Tara Powder FP. It also develops and trades food blends. The companyoffers its products to a wide range of industries including food and beverage, pharmaceutical, health care, cosmetics, leather tanning, and pet food. Exandalprincipally operates in Peru, Hungary and the US. The company distributes its products across North America, South America, Asia Pacific, Africa and the Middle East. Exandal is headquartered in Deerfield Beach, Florida, the US.

Scope

- Detailed information on Exandal Corp. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Exandal Corp. in the form of a SWOT analysis
- An in-depth view of the business model of Exandal Corp. including a breakdown and examination of key business segments
- Intelligence on Exandal Corp. ‘s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Exandal Corp. , such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Exandal Corp. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Exandal Corp. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Exandal Corp. ‘s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Exandal Corp. : Company Overview 6
Exandal Corp. : Overview and Key Facts 6
Exandal Corp. : Overview 6
Exandal Corp. : Key Facts 6
Exandal Corp. : Major Products and Services 7
Exandal Corp. : Company History 8
Exandal Corp. : Locations and Subsidiaries 9
Exandal Corp. : Key Competitors 10
Exandal Corp. : Company Analysis 11
Exandal Corp. : Business Description 11
Exandal Corp. : SWOT Analysis 12
Exandal Corp. : SWOT Overview 12
Exandal Corp. : Strengths 12
Exandal Corp. : Weaknesses 12
Exandal Corp. : Opportunities 13
Exandal Corp. : Threats 13
Appendix 15
Contact Us 15
Methodology 15
About MarketLine 16

List of Tables
Table 1: Exandal Corp. : Key Facts
Table 2: Exandal Corp. : Company History
Table 3: Exandal Corp. : Locations and Subsidiaries
Table 4: Exandal Corp. : Key Competitors



★海外企業調査レポート[Exandal Corp.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altacor Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products comprise liquid gel, eye drop, eye mask, eyelid cleaner, nutritional supplement, and others. Altaco …
  • Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Houston American Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Houston American Energy Corp (Houston American Energy) is an oil and gas company that provides exploration and development services. The company concentrates on development, exploration, …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Acer Inc (2353):企業の財務・戦略的SWOT分析
    Acer Inc (2353) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Spark Infrastructure Group:企業の発電所・SWOT分析2018
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • LIG Nex1 Co., Ltd.:企業の戦略・SWOT・財務情報
    LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary LIG Nex1 Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gulf Holding Company:企業の戦略的SWOT分析
    Gulf Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Puracap Pharmaceutical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Puracap Pharmaceutical LLC (PuraCap) is a drug development company that offers prescription generics and OTC products. The company provides over the counter soft gels and oral solid dosage healthcare products for upper respiratory, pain relief, cough and cold, sleep aid, gastrointestinal, an …
  • Kiewit Corp:企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Alkermes Plc (ALKS):製薬・医療:M&Aディール及び事業提携情報
    Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspen …
  • Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabri …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Naturex SA:企業の戦略・SWOT・財務情報
    Naturex SA - Strategy, SWOT and Corporate Finance Report Summary Naturex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • LCC International, Inc.:企業の戦略的SWOT分析
    LCC International, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Metacrine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Metacrine Inc (Metacrine) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for the treatment of patients with liver and gastrointestinal diseases. The company develops its proprietary portfolio of non-bile acid FXR agonists through its chemistry and …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. Its PledOX drug is used to prevent chemotherapy-induced side effects for colore …
  • MOL Group:企業の戦略・SWOT・財務情報
    MOL Group - Strategy, SWOT and Corporate Finance Report Summary MOL Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Mayo Clinic-医療機器分野:企業M&A・提携分析
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆